Changes in Cognition and Psychiatric Disorder Symptoms During Cannabis Abstinence Using a Novel Discordant Twin Design
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT05160688
- Status
- Enrolling By Invitation
Conditions
- Cannabis
Eligibility Criteria
- Sex
- ALL
- Age
- 31 Years - 47 Years
- Healthy Volunteers
- Accepted
Interventions
- Contingency management — BEHAVIORALParticipants will be paid to abstain from cannabis use.
Study Details
This study will test whether 42 days of cannabis abstinence, compared to continued cannabis use, is associated with improvements in cognition and psychiatric disorder symptoms. Identical twins, who are concordant on cannabis use, will be experimentally-manipulated to be discordant for 42 days. Each twin, within a twin pair, will be randomly assigned to either the contingency management condition, incentive-based protocol to promote cannabis abstinence, or control condition, no changes in cannabis use requested.
Key Dates
- Start date
- May 5, 2023
- Status verified
- Feb 2026
- Primary completion
- Apr 1, 2026
- Completion
- Apr 1, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Contingency managementContingency management (CM) is an incentive-based intervention providing patients with tangible rewards as reinforcement for positive behaviors like abstinence from drug use. Incentives are provided with each urine sample that is drug-free and are increased with each subsequent drug-free urine sample. Participants in the CM condition will receive increasing payments for abstinence: $30 on day 3, $45 on day 5, $60 on day 7, $75 on day 14, $90 on day 21, $105 on day 28, and $120 on day 42. Participants in both conditions also receive increasing payment for visit attendance: $10 on day 1, $15 on day 3, $20 on day 5, $25 on day 7, $30 on day 14, $35 on day 21, $45 on day 28, and $55 on day 42. At the end of the baseline visit, participants in the CM condition will sign a behavioral contract with study staff that clearly outlines expectations as well as the payment schedule.
- No Intervention: No interventionParticipants in this condition will be monitored and will not receive any compensation for cannabis abstinence.
Primary Outcome Measure
Change in attention performance [ Time Frame: Change from baseline to day 42 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Jessica M Ross | Aurora | Colorado | 80045 | - |
Find similar trials in Aurora, CO
By research site
Related Studies
- Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated CustomersEnrolling By Invitation · Klein Buendel, Inc. · Golden, Colorado
- Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy HumansPHASE1 · Recruiting · Yale University · West Haven, Connecticut
- Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study IPHASE1 · Recruiting · Yale University · West Haven, Connecticut
- Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study IIPHASE1 · Recruiting · Yale University · West Haven, Connecticut